Research & Clinical Trials

Our Focus

It’s about offering hope, improving outcomes, and contributing to the broader mission of scientific progress in neurology. 

Currently Enrolling Studies: 

Corrona/CorEvita - MS Registry for patients with Multiple Sclerosis. 

ALXN-MG-501- Myasthenia Gravis registry

EFC17919- Frexalt- Study comparing the efficacy and safety of frexalimab to teriflunomide. This is for patients with relapsing MS. 

FILIOS-Kesimpta- For relapsing MS to study maintenance dosing regimen of ofatumumab.

ENABLE- Briumvi- For relapsing MS. Real world experience with BRIUMVI® A longitudinal registry study.

MINT-C- Chronic Migraine- Phase 3 trial with extension period to evaluate Xeomin injections. 

Mint-E - Episodic Migraine- Evaluate efficacy and safety of Xeomin injections for the prevention of episodic migraines. 

C4951063- Menstrual Migraines- Double blind study to investigate intermittent prevention of menstrual migraine with Rimegepant compared to placebo in women 18-45

EPITOME- Multicountry study to estimate the incidence of and provide best practice model for monitoring development of post-stroke spasticity. 

CorEvitas MG Registry- Myasthenia Gravis Drug Safety and Effectiveness registry. 

Mintaka/BP46016- PMS- Phase 2 study evaluating RO7268489 as add-on therapy to Ocrelizumab for progressive MS.